Literature DB >> 21484256

An emerging model for BAP1's role in regulating cell cycle progression.

Ziad M Eletr1, Keith D Wilkinson.   

Abstract

BRCA1-associated protein-1 (BAP1) is a 729 residue, nuclear-localized deubiquitinating enzyme (DUB) that displays tumor suppressor properties in the BAP1-null NCI-H226 lung carcinoma cell line. Studies that have altered BAP1 cellular levels or enzymatic activity have reported defects in cell cycle progression, notably at the G1/S transition. Recently BAP1 was shown to associate with the transcriptional regulator host cell factor 1 (HCF-1). The BAP1/HCF-1 interaction is mediated by the HCF-1 Kelch domain and an HCF-1 binding motif (HBM) within BAP1. HCF-1 is modified with ubiquitin in vivo, and ectopic studies suggest BAP1 deubiquitinates HCF-1. HCF-1 is a chromatin-associated protein thought to both activate and repress transcription by linking appropriate histone-modifying enzymes to a subset of transcription factors. One known role of HCF-1 is to promote cell cycle progression at the G1/S boundary by recruiting H3K4 histone methyltransferases to the E2F1 transcription factor so that genes required for S-phase can be transcribed. Given the robust associations between BAP1/HCF-1 and HCF-1/E2Fs, it is reasonable to speculate that BAP1 influences cell proliferation at G1/S by co-regulating transcription from HCF-1/E2F-governed promoters.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484256      PMCID: PMC3128820          DOI: 10.1007/s12013-011-9184-6

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  66 in total

Review 1.  Protein regulation by monoubiquitin.

Authors:  L Hicke
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  Unified nomenclature for the winged helix/forkhead transcription factors.

Authors:  K H Kaestner; W Knochel; D E Martinez
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 3.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

Review 4.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells.

Authors:  J Wysocka; P T Reilly; W Herr
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Authors:  M Gunther; M Laithier; O Brison
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

7.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

8.  The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP.

Authors:  J L Vogel; T M Kristie
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

9.  E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.

Authors:  Shweta Tyagi; Winship Herr
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

10.  The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

Authors:  Yuichi J Machida; Yuka Machida; Ajay A Vashisht; James A Wohlschlegel; Anindya Dutta
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

View more
  50 in total

Review 1.  The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer.

Authors:  Lili Liao; Joseph R Testa; Haifeng Yang
Journal:  Cancer Genet       Date:  2015-02-20

2.  Contribution of active site glutamine to rate enhancement in ubiquitin C-terminal hydrolases.

Authors:  David A Boudreaux; Joseph Chaney; Tushar K Maiti; Chittaranjan Das
Journal:  FEBS J       Date:  2012-02-27       Impact factor: 5.542

3.  Decoding ubiquitin for mitosis.

Authors:  Sadek Fournane; Ksenia Krupina; Charlotte Kleiss; Izabela Sumara
Journal:  Genes Cancer       Date:  2012-11

4.  Deubiquitinating enzyme BAP1 is involved in the formation and maintenance of the diapause embryos of Artemia.

Authors:  Fan Yang; Sheng-Nan Jia; Yan-Qin Yu; Xiang Ye; Jun Liu; Ye-Qing Qian; Wei-Jun Yang
Journal:  Cell Stress Chaperones       Date:  2012-02-29       Impact factor: 3.667

5.  New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.

Authors:  Marc Ladanyi; Marjorie G Zauderer; Lee M Krug; Tatsuo Ito; Robert McMillan; Matthew Bott; Filippo Giancotti
Journal:  Clin Cancer Res       Date:  2012-07-23       Impact factor: 12.531

6.  BAP1 is phosphorylated at serine 592 in S-phase following DNA damage.

Authors:  Ziad M Eletr; Luming Yin; Keith D Wilkinson
Journal:  FEBS Lett       Date:  2013-11-05       Impact factor: 4.124

7.  Prognostic significance of BRCA1-associated protein 1 in colorectal cancer.

Authors:  Jianjun Tang; Shaoyan Xi; Gang Wang; Boqing Wang; Shumei Yan; Yuanzhong Wu; Yi Sang; Wenjing Wu; Ruhua Zhang; Tiebang Kang
Journal:  Med Oncol       Date:  2013-03-23       Impact factor: 3.064

Review 8.  Connecting molecular pathways to hereditary cancer risk syndromes.

Authors:  Joseph R Testa; David Malkin; Joshua D Schiffman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

9.  A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

Authors:  Megan N Farley; Laura S Schmidt; W Marston Linehan; James Brugarolas; Jessica L Mester; Samuel Pena-Llopis; Andrea Pavia-Jimenez; Alana Christie; Cathy D Vocke; Christopher J Ricketts; James Peterson; Lindsay Middelton; Lisa Kinch; Nick Grishin; Maria J Merino; Adam R Metwalli; Chao Xing; Xian-Jin Xie; Patricia L M Dahia; Charis Eng
Journal:  Mol Cancer Res       Date:  2013-05-24       Impact factor: 5.852

10.  PBRM1 and BAP1 as novel targets for renal cell carcinoma.

Authors:  James Brugarolas
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.